Karyopharm enters forbearance agreement
Karyopharm secured a forbearance and limited waiver from key creditors, allowing time to rectify covenant breaches and avoid default. The agreement also secures necessary waivers from holders of convertible notes.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day